Counts and rates of unintentional overdose deaths, stratified by demographic and geographic factors. In 2020, there were over 2,000 overdose deaths, an increase compared with 2019. Opioids were involved in 85% of overdose deaths.
This brief presents provisional 2019 mortality data and describes demographic and geographic characteristics of drug overdose deaths, as well as trends over the past 20 years.
Analysis of qualitative interviews with NYC cisgender Men Who Have Sex With Men who use crystal methamphetamine, to understand drug use affects. Recommendations for service providers to engage in harm reduction included.
Pursuant to section 17-711 of the New York City Administrative Code, this report describes the administration and enforcement of the Tobacco Product and Regulation Act.
This report summarizes the administration and enforcement of the Tobacco Product Regulation Act (New York City Administrative Code §17-701 et seq.), which governs the sale of tobacco products to persons under the age of 21.
Pursuant to Local Law 25 of 2018, the New York City Department of Health and Mental Hygiene published these age appropriate educational materials on opiates awareness and prevention.
In accordance with the New York City Administrative Code §17-1001 (as amended by Local Law No. 19 of 2005), this report summarizes the Prescription Drug Discount Card Program, known as BigAppleRx, updated to include the period January 1, 2022, to December 31, 2022.
This report provides updates to opioid training programs to certain individuals in administering opioid antagonists at the HRA’s HIV AIDS Services Administration (HASA) and the Department of Homeless Services.
HRA’s HASA implemented an opioid overdose training plan. DHS strengthened its naloxone training practice by requiring staff from all shelters to participate in comprehensive naloxone trainings to ensure shelters across the city are equipped to administer the life-saving drug at all times.
This report provides updates to opioid training programs to certain individuals in administering opioid antagonists at the HRA’s HIV AIDS Services Administration (HASA) and the Department of Homeless Services.
Pursuant to Admin Code Sect. 14-176, this quarterly report contains information on the # of opioid antagonists the dept has available, the # of officers trained to administer opioid antagonists, and the # of times the dept administered an antagonist to an overdose victim, disaggregated by borough
Pursuant to Admin Code Sect. 14-176, this quarterly report contains information on the # of opioid antagonists the dept has available, the # of officers trained to administer opioid antagonists, and the # of times the dept administered an antagonist to an overdose victim, disaggregated by borough
Pursuant to Admin Code Sect. 14-176, this quarterly report contains information on the # of opioid antagonists the dept has available, the # of officers trained to administer opioid antagonists, and the # of times the dept administered an antagonist to an overdose victim, disaggregated by borough
This report presents data from Relay, a peer-led nonfatal overdose response system implemented in 2017 to engage individuals during an ED visit for a suspected opioid overdose. Using a harm reduction approach, Relay Wellness Advocates responded to over 2,700 suspected nonfatal overdoses in 2021.
The New York City Municipal Drug Strategy Council (MDSC) C is a body of government and community experts in substance use care and treatment, with a shared goal of reviewing and enhancing NYC's drug strategy. This report includes an overview of current drug strategy and offers recommendations..
The New York City Municipal Drug Strategy Council (MDSC) is a body of government and community experts in substance use and substance use care and treatment. This report includes an overview of current drug strategy and progress made during the past two years and offers recommendations.
Pursuant to Local Law 48 of 2016, this report is presented by the New York City Municipal Drug Strategy Council (MDSC) and includes recommendations to enhance the City's drug strategy.
The NYC Municipal Drug Strategy Council (MDSC) is a body of government and community experts in substance use, with a shared goal to review and enhance New York City's drug strategy. This report includes a review of current drug strategy and progress, and recommendations for the future.